In general, the circadian system adapts either partially or not at all to night shift work. 9, 10 However previous research in unusual circumstances (e.g., working 18.00-06.00 h on offshore oil rigs and 20.00-08.00 h in Antarctica) has reported that shift workers can fully adapt to the night shift schedule within a week. 11, 12 If shift workers fully adapt to a night shift offshore they will be out of synchrony with their home environment upon returning home, with consequent problems of poor night sleep, reduced daytime alertness and performance and possible digestive problems. Factors such as season, 13 length and timing of the shift, 12, 14 early or late initial circadian phase, 15 light exposure 9 and sleep/wake patterns (as these indirectly affect light exposure), may all affect circadian adaptation. The use of light treatment at home, appropriately timed, may alleviate/reduce the physiological and behavioral problems caused by circadian rhythm disturbance experienced following offshore night shift work. 5, 16 Light has been suggested as a counter measure against night work impairment of sleep and alertness. 10, 17 Intense artificial light can shift the phase of the human circadian timing system and has been successfully used to induce phase shifts in circadian rhythms and to improve sleep, performance and alertness. [18] [19] [20] [21] Bright light as a counter measure for circadian desynchrony has also been used in field studies of shift workers, though the number of studies is limited. 16, [22] [23] [24] Recent research has shown the effectiveness of short wavelength blue light to phase shift human circadian rhythms 25, 26 and increase alertness. 21, 27, 28 Recently Bjorvatn et al. 16 evaluated the effects of bright light and melatonin in offshore shift workers working a 'swing shift' schedule. Subjective and objective measures of sleep were obtained. Melatonin reduced sleepiness at work during the day shift and increased sleep by [15] [16] [17] [18] [19] [20] mins per day, whilst bright light gave values in between those of melatonin and the placebo, but with few statistically significant results. In these studies the effect of melatonin and light on circadian phase was not investigated. The aim of this study was to investigate sleep and circadian adaptation in offshore night shift workers returning to day life at home after adapting to the night shift offshore. We hypothesized that timed light treatment would improve night sleep at home and would shift the circadian rhythm of urinary 6-sulphatoxymelatonin (aMT6s) compared to a "no light treatment"
condition.
METHODS

Pre-study
Ethical permission was obtained from the University of Surrey Ethics Committee (ACE/2002/95SBLS). Before starting the study, written informed consent was obtained from all volunteers. Subjects had to be working a 2-3 week night shift and were free of any medication known to affect the melatonin rhythm (β-blockers, α-blockers, calcium channel blockers, antipsychotics, benzodiazepines, antidepressants, barbiturates and antiepileptic drugs). Diurnal preference was assessed using the Horne Östberg (HÖ) questionnaire.
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Subjects
Eight men (S1-S8) aged 46 ± 11 years (mean ± SD), body mass index (BMI) 28.1 ± 2.5 kg/m 2 , HÖ score 57 ± 8, working a 19.00-07.00 h shift schedule offshore, on an oilrig platform in the North Sea at 58°N for 14 or 21 consecutive nights were recruited during the summer months (May-August, 2005). Six men (S9-S14) aged 49 ± 7 years (mean ± SD), BMI 28.4 ± 2.1 kg/m 2 , HÖ score 58 ± 4, working a 18.00-06.00 h shift schedule offshore in the North Sea at 59°N for 14 consecutive nights were recruited during the winter months (October-March, 2006).
All subjects returned home onshore after finishing their night shift.
Study design
Subjects were studied for 21 days, namely the last 7 days offshore of a 2 or 3 week
19.00-07.00 h night shift or the last 7 days offshore of a 2 week 18.00-06.00 h night shift, and for They wore an Actiwatch-L (Cambridge Neurotechnology, Cambridge, UK) for 21 days to record light exposure and activity in one-minute epochs. The subjective sleep parameters recorded were sleep onset, defined as the time the subject went to sleep, sleep offset defined as the time the subject woke up, sleep latency, number of night awakenings and sleep quality (1 = best ever sleep, 9 = worst ever sleep). In the actigraphy analysis sleep onset, offset, efficiency and fragmentation index were analyzed. Light exposure (lux) derived from the Actiwatch-L was analyzed in 1 h bins on days 1-5 at home after the night shift to determine the timing of brightest daily light exposure period of each individual subject.
Subjects collected sequential urine samples to assess circadian adaptation to the night shift and readaptation after the night shift. Samples were collected approximately every 4 h during waking hours and longer over the sleep period during the last 2 days (48 h) of the night shift offshore and the 7 consecutive days after the night shift at home.
6-sulphatoxymelatonin analysis
The volume of each sample was measured and a 5 ml aliquot was frozen and transported to the University of Surrey for analysis. 6-sulphatoxymelatonin was measured by radioimmunoassay, 30 with reagents provided by Stockgrand Ltd, UK. Interassay coefficients of variation at 4.7 ng/ml (n = 14), 14.9 ng/ml (n = 19) and 25.0 ng/ml (n = 15) were 10.0%, 9.9% and 9.4%, respectively. The aMT6s acrophase (individual daily mean peak time for the last 3 days of night shift, and the 7 consecutive days afterwards) was calculated from cosinor analysis of each 24 h period (programme developed and kindly provided by Dr D.S. Minors, University of Manchester, UK). Acrophase values were only accepted if the cosinor fit was significant at the 95% level or if the fit was significant at >80% level and the variance (percentage rhythm)
accounted for by the cosine curve was greater than 50%. Circadian adaptation offshore was defined as when the aMT6s acrophase occurred during the day sleep period. Acrophase time is given in decimal hours. 
Light treatment protocol
The study was a randomized crossover design with two study sessions, one where the subject received timed light treatment and wore sunglasses at appropriate times upon returning home, and a second session where the sample collection protocol was the same but light treatment was not given and sunglasses were not worn. White polychromatic light (~3000 lux, 1000 µW/cm 2 ) was administered using a light box (Litebook ® Alberta, Canada). Previous studies by Gibbs et al. 12 showed that the peak of the aMT6s rhythm of subjects leaving the oil rig after working 1 week of night shifts (18.00-06.00 h) was 12.98 ± 0.50 h. From the findings of this previous study, the light treatment protocol was designed as follows: Day 1 was the day the subjects returned home onshore, and they were asked to wear specialized light blocking sunglasses (Litebook ® ) from the end of their night shift until 13.00 h on day 1. On day 2 subjects wore sunglasses from wake up until 13.00 h and then received light treatment by sitting in front of the Litebook ® for 1 h, with the device placed at a 45 degree angle, 30 cm in distance away from their eyes. For the following 3 days (days 3-5) the light was scheduled an hour earlier each day with subjects wearing sunglasses from wake up until the beginning of the light treatment. This protocol was used for those subjects working the 19.00-07.00 h night shift (n=8).
Due to the observed variability of results from the 19.00-07.00 h study, it was decided for the subsequent study for those working a 18.00-06.00 h shift schedule that the light treatment should be individually timed to phase advance the circadian system. This part of the study was thus not randomized as subjects completed the "no light treatment" leg first to allow the aMT6s rhythm offshore to be analyzed, and then in the second study leg the light treatment was individually timed on the basis of their aMT6s results. Subjects whose offshore aMT6s acrophase was between 11.00-15.00 h followed the protocol as described above (n=7). One subject had an offshore aMT6s acrophase between 15.00-17.00 h and thus started his light treatment on day 2 at 14.00 h. The rate of adaptation back to home time between the light and no light treatment legs was calculated using the following equation: (aMT6s acrophase on day 5 -mean aMT6s night shift acrophase for the last 2 days (days -2 and -1) offshore) / number of days (=5)).
Rate of adaptation
Statistical analysis
The data from the two shift schedules were grouped together. Statistical analysis (paired Student's t-test) was performed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).
Statistical significance was set at P < 0.05. All values are mean ± SD.
RESULTS
No significant differences were observed in the subjects working the two shift schedules (18.00-06.00 h and 19.00-07.00 h) in terms of age, BMI and HÖ score. In the 19.00-07.00 h shift schedule, two subjects (S1 and S2) did not adapt to the night shift, mean (± SD) aMT6s
acrophases for the last two days offshore were 4.3 ± 0.4 h and 5.3 ± 0.5 h for S1 and S2, respectively. As a result these two subjects were excluded from any further analysis. Two subjects (S3 and S7) only completed one leg of the study and were also excluded from further analysis. Two subjects (S4 and S14) completed sleep diaries and these results are included in the analysis but no actigraphy data were obtained and therefore no light exposure analysis could be performed. One subject (S9) collected urine for only one study session; these data were therefore not included in the circadian phase analysis. In total ten subjects were included in the sleep analysis, mean age 46.5 ± 7.8 years, BMI 28. ± 2.0 kg/m 2 and HÖ score 55 ± 5.
Prior sleep history
Sleep (sleep diaries and actigraphy) prior to the light treatment schedule was assessed for 7 days offshore (days -7 to -1), as shown in Table 1 . Sleep diary sleep duration was 6.79 ± 0.90 h, whilst actigraphic sleep duration was 5.89 ± 0.65 h. 
Circadian phase
No significant differences (P > 0.05) were observed in the mean aMT6s acrophase during the last two days of their night shift offshore between the no light treatment (14.3 ± 2.5 h) and light treatment leg (15.0 ± 1.5 h) (paired Student's t-test). No significant differences were observed in the rate of aMT6s adaptation between the light and no light treatment legs for those subjects who had data for both study sessions (n=9). The mean rate of aMT6s adaptation in the no light treatment leg was 2.00 ± 0.45 h/day (mean ± SD) and in the light treatment leg the mean rate of aMT6s adaptation was 2.16 ± 0.86 h/day. In the light treatment session, 2 subjects adapted by phase advance, whilst 7 phase delayed whereas in the no light treatment session 8 subjects adapted by phase delay and 1 subject phase advanced (Table 2) .
Light exposure
No significant differences were observed in the mean timing of the brightest light exposure (P > 0.05) between the study legs (days 1-5 on returning onshore) ( Table 2 ). In the light treatment leg the brightest light exposure period occurred between 10.0-14.0 h (mean 12.9 ± 3.2 h) for all of the subjects and in the no light treatment leg the brightest light exposure period occurred between 11.0-16.6 h (mean 13.3 ± 2.7 h) for all of the subjects ( Table 2 ). However significant differences were observed between the light treatment and no light treatment leg (P = 0.05) in terms of the amount of bright light exposure that occurred during this time period. In the no light treatment leg, mean light exposure was 2252 ± 1631 lux, whilst in the light treatment leg mean light exposure was increased to 4644 ± 2602 lux. Light exposure, however, was very variable between subjects, with two subjects (S10 and S13) showing little evidence of extra light exposure during the light treatment leg. 
Sleep
Sleep analysis after the night shift was separated into days 1-5 (during the light exposure treatment) and days 6-14 (which were chosen as the main descriptive analysis for all sleep diary and actigraphy data). This allowed a direct comparison between the light and no light treatment legs as days 2-5 could have been affected directly by the light treatment.
Actigraphic sleep
Individual actigraphy data for the light and no light treatment legs for days 1-5 and days 6-14 are shown in Tables 3a and b, respectively.
[ Table 3a about here]
[ Table 3b about here]
During days 1-5 there was a significant increase (P = 0.05) in the sleep efficiency in the light treatment session (86.7 ± 5.8%) compared to the no light treatment session (79.4 ± 10.3%).
No other statistical differences in actigraphic sleep were observed between the two study conditions. During days 6-14 the following differences were observed: sleep onset was [ Table 4a about here]
[ Table 4b about here]
During days 1-5 no significant differences in subjective sleep were observed between the light and no light conditions. During days 6-14, however, there was a significant increase in 
DISCUSSION
Analysis of the participants' light exposure revealed that the natural bright light exposure was in most subjects (6 out of 8) greater (6105 ± 3444 lux) than the light treatment (3000 lux)
itself. In the light treatment leg, on day 1 after the night shift all subjects (n=5) with an available aMT6s acrophase received the brightest natural light exposure before their peak of melatonin. In the no light treatment leg 3 subjects received their brightest natural light exposure before the peak of melatonin on day 1, and 2 subjects received their brightest natural light exposure after Table 2 ). If the subjects wore sunglasses as instructed this should have counteracted the delaying natural light exposure, however the limited evidence suggests that in fact most subjects in both study legs adapted by delay to home time. To force a phase advance in these circumstances, the avoidance of conflicting light (e.g. by wearing sunglasses) is likely to be more important than the light treatment itself.
During the first 5 days after the night shift significant differences were only observed in actigraphic sleep efficiency, which was substantially improved by light treatment (79 to 87%). 24 who assessed circadian phase (aMT6s) tested light treatment in a field study in subjects who were working night shifts in Antarctica. They reported improvement in sleep latency with timed bright light treatment. Our study, along with Ross et al., 24 attempted to investigate in the field if these beneficial findings on sleep were related to circadian phase, which this study failed to demonstrate.
Lastly Bjorvatn et al. 5 investigated offshore shift workers and reported the effects of 30 mins of bright light treatment (~10,000 lux) given for 4 days upon returning home after completion of the 2 week night shift. Light exposure was scheduled individually to phase delay the circadian system, based on the assumption that the circadian nadir was located 2 h before the subject's habitual time of awakening. Light treatment reduced self-rated sleepiness, though in this study circadian phase was not assessed. The shift workers studied here slept on average less than a cohort studied by Vorona et al. 32 Vorona and colleagues reported that men (n=288) aged 18-91 years with a BMI of [25] [26] [27] [28] [29] kg/m 2 and assessed with a sleep questionnaire, slept on average 7.57 h. In the no light treatment leg, subjects' subjective sleep duration was on average (days 6-14) slightly less (7.32 ± 0.55 h) than that studied by Vorona et al. 32 In our study the improvements in sleep duration during and after light treatment could not be attributed to different rates of circadian adaptation as there were no observed differences in the rate of adaptation between the light treatment and no light treatment legs. This may be due to a number of factors; firstly compliance with the urine sample collection protocol was variable.
Secondly, natural light exposure during the day could have suppressed melatonin production, and therefore calculation of the timing of the aMT6s acrophase would have been affected. In addition, the aMT6s acrophase time on the last days offshore was rather later than we had anticipated, and thus the scheduled timing of light treatment may not have been optimal to phase advance the circadian system in some cases, for example subjects S11 and S9. Natural light exposure received after removing sunglasses and the light treatment and received before the peak aMT6s may have been partly responsible for the observed phase delays.
The findings of this study thus suggest that the effect of light on sleep is not being mediated via circadian adaptation. Light can potentially affect sleep in several other ways e.g.
increased circadian amplitude, increased sleep duration with a change in photoperiod, increased daytime activity and consequently better night sleep. [33] [34] [35] [36] Recent publications 37, 38 demonstrate that light acting via melanopsin can directly affect sleep. The Litebox used in this study delivers white light in the visible range (400-480 nm) with a peak at 460-480 nm (blue wavelength), and the maximal sensitivity of the melanopsin photopigment is known to be in the blue range. Subject motivation may also be very important given that it is virtually impossible to blind such light experiments. The subjects recruited in this field study were motivated to try out the light treatment hoping that it would reduce their complaints of feeling 'jet-lagged' upon returning home from night shift. This may have provoked them to provide more positive subjective sleep scores following the bright light treatment. By contrast, more statistically significant differences between the light and no light conditions were observed in the objective actigraphic sleep measures than in the subjective sleep diary measures. These findings argue against a "placebo" effect of light. However, as the sleep diary data (sleep onset; sleep offset)
were used for the actigraphy analysis, this may have added some element of bias towards the light treatment study session.
As with any field study, certain conditions such as natural light exposure or subject compliance with study instructions cannot be completely controlled. There is no control of the seasonal and daily changes in the outdoor levels of light; though participating subjects completed both study legs in the same season, either summer or winter. Subjects were asked when participating in the light treatment leg to wear the sunglasses provided at certain times; however there was no way of checking that this had actually occurred. In addition, clothing covering the light monitor cannot be strictly controlled although subjects were instructed to wear the activity/light monitor on the outside of the clothing over their sleeves, and to wear it continuously apart from when bathing. Despite these limitations light treatment significantly improved some sleep parameters.
It is possible either to phase advance the timing of the circadian system, if light exposure is timed on the declining phase of the melatonin rhythm, or to phase delay the circadian system if light exposure is timed on the rising phase of the melatonin rhythm. [41] [42] [43] Thus if bright light exposure occurs at the 'wrong' time, this may lengthen the time in which it takes to readapt back 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  R  e  v  i  e  w  O  n  l  y   13 to day life, though if subjects are very phase delayed, which was the case for those working the 19.00-07.00 h shift schedule, it may be better to phase delay the melatonin rhythm rather than impose phase advances.
There was a clear beneficial effect of light treatment on some sleep parameters, however, due to the study design using both light and sunglasses it cannot be determined if it was the light treatment, the avoidance of light or a combination of the two which was responsible for the observed effect. This ambiguity could only be resolved if two additional study legs were carried out: subjects wearing sunglasses only and subjects only being exposed to light. This study has demonstrated that timed light treatment administered to hasten adaptation to day life after working night shift significantly improved both actigraphic and subjective sleep duration as well as actigraphic sleep efficiency. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
